


Able Cerebral Revenue
Biotechnology Research • Ephrata, Pennsylvania, United States • 1-10 Employees
Able Cerebral revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at Able Cerebral
Jon Xia
Founder / President
Company overview
| Headquarters | 55 new street,, Ephrata, Pennsylvania 17522, US |
| Phone number | +17178145752 |
| Website | |
| SIC | 283 |
| Keywords | Prevent And Reverse Cognitive Impairment And Ad, Targeting Nocturnal Hypoglycemia, Wearable Medical Device, Brain Energy Delivery |
| Founded | 2012 |
| Employees | 1-10 |
| Socials |
Able Cerebral Email Formats
Able Cerebral uses 1 email format. The most common is {first initial} (e.g., j@ablecerebral.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@ablecerebral.com | 100% |
About Able Cerebral
Able Cerebral, LLC (ACL) is located in Ephrata, Pennsylvania, USA. ACL owns US, Canada and Chinese patents and patent applications. Innovation in technologies and therapeutic methods are among the core values of the company. ACL is a unique worldwide leader in timed brain energy delivery and circadian / chronotherapy for CNS diseases. ACL is currently transforming into a bio-pharmaceutical and medical device entity. ACL’s 1st innovative product BrainGlucose since 2013, has saved precious memories for Alzheimer's, diabetics, cancer patients on Chemo, and Parkinson's patients; the 2nd product under development AddMem (Alzheimer's disease & dementia Memory enhancing method) would be also a breakthrough therapeutic system (Device) in the world for memory retain and recovery for late stage Alzheimer's disease and Traumatic Brain Injury (TBI). ACL is proud to announce that, our first product BrainGlucose has gained great reputation within Alzheimer's patients and their caregivers. It stops AD patients nightmares, night sweats, and early morning hallucinations so they will not deteriorate to late stage and keep their dignity and relatively independent lifestyle. BrainGlucose has also been loved by many diabetics to prevent noctunal hypoglycemia (post midnight low blood sugar), and weight gain. ACL is actively seeking investment and joint ventures to co-develop our brain energy product and memory recovery project by applying for FDA approval as breakthrough drugs and non invasive medical device (AddMem).
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Able Cerebral has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Able Cerebral has never raised funding before.
Able Cerebral Tech Stack
Discover the technologies and tools that power Able Cerebral's digital infrastructure, from frameworks to analytics platforms.
Video players
Security
Security
Video players
CDN
JavaScript libraries
CMS
Programming languages
Analytics
Tag managers
Hosting
Frequently asked questions
4.8
40,000 users



